Retour
Fourchette du Jour
35,44 €
36,34 €
Fourchette 52 Semaines
21,97 €
48,25 €
Volume
221 362
Moyenne 50J / 200J
39,51 €
/
39,76 €
Clôture Précédente
35,70 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 177,1 | 0,2 |
| P/B | 3,9 | 3,0 |
| ROE % | 2,7 | 3,5 |
| Net Margin % | 2,2 | 3,8 |
| Rev Growth 5Y % | 10,2 | 9,7 |
| D/E | 0,7 | 0,2 |
Objectif de Cours des Analystes
Hold
52,00 €
+44.0%
Low: 50,00 €
High: 55,00 €
P/E Prévisionnel
101,15
BPA Prévisionnel
0,36 €
Croissance BPA (est.)
+0,0%
CA Est.
494,14M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,72 €
1,69 € – 1,73 €
|
787,30M | 1 |
| FY2029 |
1,33 €
1,31 € – 1,34 €
|
697,90M | 1 |
| FY2028 |
0,87 €
0,76 € – 0,97 €
|
616,15M | 2 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-12 | 0,06 € | 0,17 € | +203,6% |
| 2025-11-06 | 0,14 € | 0,16 € | +14,3% |
| 2025-08-07 | 0,11 € | 0,24 € | +118,2% |
| 2025-05-05 | 0,12 € | 0,06 € | -50,0% |
| 2025-02-24 | 0,12 € | -0,39 € | -425,0% |
| 2024-11-07 | 0,10 € | 0,12 € | +20,6% |
| 2024-08-08 | -0,49 € | 0,07 € | +114,3% |
| 2024-05-06 | 0,02 € | 0,06 € | +170,3% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Dec 09, 2015 | Dec 18, 2015 | 0,03 € | 1,15% |
| Sep 09, 2015 | Sep 18, 2015 | 0,03 € | 1,24% |
| Jun 10, 2015 | Jun 19, 2015 | 0,03 € | 1,07% |
| Mar 11, 2015 | Mar 20, 2015 | 0,03 € | 1,16% |
| Dec 10, 2014 | Dec 19, 2014 | 0,03 € | 1,12% |
| Sep 10, 2014 | Sep 19, 2014 | 0,03 € | 1,15% |
| Jun 11, 2014 | Jun 20, 2014 | 0,03 € | 1,25% |
| Mar 12, 2014 | Mar 21, 2014 | 0,03 € | 1,16% |
| Dec 11, 2013 | Dec 20, 2013 | 0,03 € | 1,06% |
| Sep 11, 2013 | Sep 20, 2013 | 0,03 € | 1,64% |
| Jun 12, 2013 | Jun 21, 2013 | 0,03 € | 1,67% |
| Mar 12, 2013 | Mar 21, 2013 | 0,03 € | 1,22% |
| Dec 12, 2012 | Dec 21, 2012 | 0,03 € | 0,83% |
| Sep 12, 2012 | Sep 21, 2012 | 0,03 € | 0,45% |
Points Clés
Revenue grew 10,24% annually over 5 years — strong growth
ROE of 2,70% is below average
Negative free cash flow of -911 000,0
P/E of 177,06 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,35%
Capital efficient — spends only 8,85% of revenue on capex
Croissance
Revenue Growth (5Y)
10,24%
Revenue (1Y)13,59%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
2,70%
ROIC2,71%
Net Margin2,21%
Op. Margin6,06%
Sécurité
Debt / Equity
0,65
Current Ratio2,99
Interest Coverage1,01
Valorisation
P/E Ratio
177,06
Forward P/E101,15
P/B Ratio3,86
EV/EBITDA73,16
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13,59% | Revenue Growth (3Y) | 11,65% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 10,24% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 441,33M | Net Income (TTM) | 9,77M |
| ROE | 2,70% | ROA | 1,10% |
| Gross Margin | 61,28% | Operating Margin | 6,06% |
| Net Margin | 2,21% | Free Cash Flow (TTM) | -911 000,0 |
| ROIC | 2,71% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,65 | Current Ratio | 2,99 |
| Interest Coverage | 1,01 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 177,06 | Forward P/E | 101,15 |
| P/B Ratio | 3,86 | P/S Ratio | 3,92 |
| PEG Ratio | -1,25 | Forward PEG | N/A |
| EV/EBITDA | 73,16 | Fwd EV/EBITDA | 40,63 |
| Forward P/S | 3,50 | Fwd Earnings Yield | 0,99% |
| FCF Yield | -0,05% | ||
| Market Cap | 1,73B | Enterprise Value | 1,96B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 441,33M | 388,54M | 354,00M | 313,79M | 298,84M |
| Net Income | 9,77M | -13,36M | -30,69M | -19,19M | -14,83M |
| EPS (Diluted) | 0,21 | -0,32 | -0,75 | -0,48 | -0,38 |
| Gross Profit | 270,45M | 248,78M | 229,18M | 202,52M | 197,51M |
| Operating Income | 26,75M | 38,87M | 5,74M | 6,20M | 8,12M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 884,80M | 789,10M | 792,40M | 762,80M | 793,05M |
| Total Liabilities | 436,56M | 512,90M | 510,62M | 478,47M | 492,32M |
| Shareholders' Equity | 448,23M | 276,20M | 281,78M | 284,33M | 300,73M |
| Total Debt | 292,04M | 362,26M | 358,34M | 356,83M | 362,04M |
| Cash & Equivalents | 64,91M | 53,46M | 58,94M | 39,35M | 55,01M |
| Current Assets | 303,55M | 290,08M | 280,67M | 247,33M | 247,70M |
| Current Liabilities | 101,56M | 66,82M | 57,86M | 49,68M | 44,95M |